Prelude Therapeutics
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Delaware, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

175 Innovation Blvd, Wilmington, Delawar...

Phone Number

(302) 467-1280

Revenue

$16.7 Million

Stock Symbol

PRLD

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Prelude Therapeutics

Founded in 2016 and headquartered in Newark, Delaware, Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth.Explore more
Prelude Therapeutics's Social MediaPopular SearchesPrelude Therapeutics IncPrelude TherapeuticsPrelude TxPrecision Development IncPreludeSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: PRLDShow more

Prelude Therapeutics Org Chart

KV
United States flag for contact location.

Chief Executive Officer & Founder

PhoneEmail
SB
United States flag for contact location.

Chief Business Officer

PhoneEmail
PS
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
CT
United States flag for contact location.

Vice President Clinical Science

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Prelude Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Prelude Therapeutics

Compare insights from companies similar to Prelude Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Prelude Therapeutics

$16.7M
51-200
Public
$273M
2016
KV
Kris VaddiCEO & Founder
$384.7M
51-200
Public
-
2018
RM
Ryan MartinsChief Financial Officer
$15M
51-200
Private
$181.5M
2015
TL
Thomas LeitchChief Technology Officer
$8M
51-200
Private
-
1956
JH
Jo HornPresident & CEO
$5.6M
11-50
Private
<$5M
2009
MF
Michael FilippoChief Financial Officer
<$5M
11-50
Public
$29.8M
1997
LW
Lauren WittberAssociate Director, Accounting, SEC Reporting & Financial Analysis
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Prelude Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Prelude Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prelude Therapeutics.

Prelude Therapeutics financials insights

Gather financial insights about Prelude Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2016

Series A

$5M

2019

Series B

$60M

2020

Series C

$50M

Stock Offering

$158M

See All Prelude Therapeutics's Financials Insights

Prelude Therapeutics Tech Stack

A closer look at the technologies used by Prelude Therapeutics

Most Recent Scoops

Person-Based
Earnings, Spending/Investment, Research & Development, Layoffs, Medical Research, Finance
Earnings
Earnings, Finance
Person-Based
Medical Research, Clinical Operations
Person-Based
Research & Development
Person-Based
Business Finance, Finance, Financing & Debt
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Prelude Therapeutics

What is Prelude Therapeutics's stock symbol?
Prelude Therapeutics's stock symbol is PRLD
What is Prelude Therapeutics's official website?
Prelude Therapeutics's official website is www.preludetx.com
What is Prelude Therapeutics's Revenue?
Prelude Therapeutics's revenue is $16.7 Million
What is Prelude Therapeutics's SIC code?
Prelude Therapeutics's SIC: 28,283
What is Prelude Therapeutics's NAICS code?
Prelude Therapeutics's NAICS: 32,325
How many employees does Prelude Therapeutics have?
Prelude Therapeutics has 51-200 employees
What industry does Prelude Therapeutics belong to?
Prelude Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Prelude Therapeutics competition?
Prelude Therapeutics top competitors include: 89bio, Swog, Community Research Initiative of New England, Transitional Care Management
What technology does Prelude Therapeutics use?
Some of the popular technologies that Prelude Therapeutics uses are: WordPress.org, PHP, Cloudflare Website Optimization, Adobe Typekit
How do I contact Prelude Therapeutics?
Prelude Therapeutics contact info: Phone number: (302) 467-1280 Website: www.preludetx.com
What does Prelude Therapeutics do?

Founded in 2016 and headquartered in Newark, Delaware, Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth.... Read More

What are Prelude Therapeutics social media links?
Prelude Therapeutics Linkedin page Prelude Therapeutics Twitter page
Who invested in Prelude Therapeutics?
Prelude Therapeutics has 5 investors including Fidelity Management & Research Company, OrbiMed Advisors LLC and OrbiMed.
Is Prelude Therapeutics a public company?
Yes, Prelude Therapeutics is a public company and is traded under the symbol PRLD
See more information about Prelude Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.